Next Article in Journal
Viral Hybrid Vectors for Somatic Integration - Are They the Better Solution?
Next Article in Special Issue
HIV-1 Subtype C Phylodynamics in the Global Epidemic
Previous Article in Journal
Interplay between Herpesvirus Infection and Host Defense by PML Nuclear Bodies
Previous Article in Special Issue
Protection against Mucosal SHIV Challenge by Peptide and Helper-Dependent Adenovirus Vaccines
Viruses 2009, 1(3), 1265-1294; doi:10.3390/v1031265
Review

Antibody-Mediated Fcγ Receptor-Based Mechanisms of HIV Inhibition: Recent Findings and New Vaccination Strategies

* ,
 and
Received: 30 September 2009; in revised form: 1 December 2009 / Accepted: 8 December 2009 / Published: 15 December 2009
(This article belongs to the Special Issue AIDS Vaccine)
View Full-Text   |   Download PDF [295 KB, uploaded 15 December 2009]   |   Browse Figure
Abstract: The HIV/AIDS pandemic is one of the most devastating pandemics worldwide. Today, the major route of infection by HIV is sexual transmission. One of the most promising strategies for vaccination against HIV sexual infection is the development of a mucosal vaccine, which should be able to induce strong local and systemic protective immunity. It is believed that both humoral and cellular immune responses are needed for inducing a sterilizing protection against HIV. Recently, passive administration of monoclonal neutralizing antibodies in macaques infected by vaginal challenge demonstrated a crucial role of FcγRs in the protection afforded by these antibodies. This questioned about the role of innate and adaptive immune functions, including ADCC, ADCVI, phagocytosis of opsonized HIV particles and the production of inflammatory cytokines and chemokines, in the mechanism of HIV inhibition in vivo. Other monoclonal antibodies - non-neutralizing inhibitory antibodies - which recognize immunogenic epitopes, have been shown to display potent FcγRs-dependent inhibition of HIV replication in vitro. The potential role of these antibodies in protection against sexual transmission of HIV and their biological relevance for the development of an HIV vaccine therefore need to be determined. This review highlights the potential role of FcγRsmediated innate and adaptive immune functions in the mechanism of HIV protection.
Keywords: neutralizing antibodies; FcγR-bearing immune cells; non-neutralizing inhibitory antibodies; mucosal HIV vaccine neutralizing antibodies; FcγR-bearing immune cells; non-neutralizing inhibitory antibodies; mucosal HIV vaccine
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Holl, V.; Peressin, M.; Moog, C. Antibody-Mediated Fcγ Receptor-Based Mechanisms of HIV Inhibition: Recent Findings and New Vaccination Strategies. Viruses 2009, 1, 1265-1294.

AMA Style

Holl V, Peressin M, Moog C. Antibody-Mediated Fcγ Receptor-Based Mechanisms of HIV Inhibition: Recent Findings and New Vaccination Strategies. Viruses. 2009; 1(3):1265-1294.

Chicago/Turabian Style

Holl, Vincent; Peressin, Maryse; Moog, Christiane. 2009. "Antibody-Mediated Fcγ Receptor-Based Mechanisms of HIV Inhibition: Recent Findings and New Vaccination Strategies." Viruses 1, no. 3: 1265-1294.


Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert